Cargando…

11例原发性骨淋巴瘤临床分析

OBJECTIVE: To analyze the clinical features, treatment and outcomes of primary lymphoma of bone (PLB). METHODS: The clinical data of 11 PLB patients were retrospectively analyzed. RESULTS: 11 patients were enrolled in our study including 7 females and 4 males. The median age of the patients was 45 y...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342277/
https://www.ncbi.nlm.nih.gov/pubmed/28810328
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.07.009
_version_ 1783555428951523328
collection PubMed
description OBJECTIVE: To analyze the clinical features, treatment and outcomes of primary lymphoma of bone (PLB). METHODS: The clinical data of 11 PLB patients were retrospectively analyzed. RESULTS: 11 patients were enrolled in our study including 7 females and 4 males. The median age of the patients was 45 years old. The main histologic type was diffuse large B cell lymphoma and anaplastic large cell lymphoma. Of the 11 PLB cases, 3 cases were at stage ⅠE, 2 at stage ⅡE, 6 at stage ⅣE respectively. 6 cases were treated with chemotherapy and radiotherapy, 2 cases with total joint arthroplasty and chemotherapy, and 3 cases chemotherapy alone respectively. 5 cases got complete remission, 4 cases partial remission and 2 cases stable disease respectively. The median progression free survival was 17 (5–58) months after a median follow up of 21 (6–58) months. CONCLUSION: Most of PLB patients were clinically in late stage lacking of clinical and imagine features. The optimal treatment for PLB was radiotherapy combined with chemotherapy, and its prognosis was relatively good.
format Online
Article
Text
id pubmed-7342277
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73422772020-07-16 11例原发性骨淋巴瘤临床分析 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To analyze the clinical features, treatment and outcomes of primary lymphoma of bone (PLB). METHODS: The clinical data of 11 PLB patients were retrospectively analyzed. RESULTS: 11 patients were enrolled in our study including 7 females and 4 males. The median age of the patients was 45 years old. The main histologic type was diffuse large B cell lymphoma and anaplastic large cell lymphoma. Of the 11 PLB cases, 3 cases were at stage ⅠE, 2 at stage ⅡE, 6 at stage ⅣE respectively. 6 cases were treated with chemotherapy and radiotherapy, 2 cases with total joint arthroplasty and chemotherapy, and 3 cases chemotherapy alone respectively. 5 cases got complete remission, 4 cases partial remission and 2 cases stable disease respectively. The median progression free survival was 17 (5–58) months after a median follow up of 21 (6–58) months. CONCLUSION: Most of PLB patients were clinically in late stage lacking of clinical and imagine features. The optimal treatment for PLB was radiotherapy combined with chemotherapy, and its prognosis was relatively good. Editorial office of Chinese Journal of Hematology 2017-07 /pmc/articles/PMC7342277/ /pubmed/28810328 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.07.009 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
11例原发性骨淋巴瘤临床分析
title 11例原发性骨淋巴瘤临床分析
title_full 11例原发性骨淋巴瘤临床分析
title_fullStr 11例原发性骨淋巴瘤临床分析
title_full_unstemmed 11例原发性骨淋巴瘤临床分析
title_short 11例原发性骨淋巴瘤临床分析
title_sort 11例原发性骨淋巴瘤临床分析
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342277/
https://www.ncbi.nlm.nih.gov/pubmed/28810328
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.07.009
work_keys_str_mv AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī
AT 11lìyuánfāxìnggǔlínbāliúlínchuángfēnxī